Retinoids in pancreatic cancer

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Riecken, Ernst Otto ^a   Rosewicz, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

IFN ; Pancreas; Protein kinase C; Retinoid receptor; Retinoids

Indexed keywords

ALPHA INTERFERON; ISOENZYME; PROTEIN KINASE C; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR;

ADULT; BLOOD TOXICITY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; ORAL DRUG ADMINISTRATION; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN TOXICITY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032807117     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S197     Document Type: Conference Paper

References (35)

1. Silverberg E, Boring CC, Squires TS. Cancer Statistics 1990. Can Canc J Clinicians 1990; 40: 9-26.
2. Bakkevold KE, Arnesjo B, Kambestag B. Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumor site. A prospective multicentre trial in 472 patients. Scand J Gastroenterol 1992; 27: 317-25.
3. Arbuck SG. Chemotherapy for pancreatic cancer. Baill Clinic Gastroenterol 1990; 4: 953-64.
4. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349: 485-9.
5. Lionetto R, Pugliese V, Bruzzi P et al. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 1995; 31A: 882-7.
6. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992; 3: 512-26.
7. Rosewicz S, Stier U, Brembeck F et al. Retinoids: effects on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 1995; 109: 1646-60.
8. Rosewicz S, Riecken EO, Stier U. Transcriptional regulation of carbonic anhydrase II by retinoic acid in the human pancreatic tumor cell line DANG. FEBS Lett 1995; 368: 45-8.
9. Egawa N, Maillet B, vanDamme B et al. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines. Virchows Arch 1996; 429: 59-68.
10. Bold RJ, Ishizuka J, Townsend CM et al. All-trans retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas 1996; 12: 189-95.
11. Moore DM, Kalvakolanu DV, Lippman SM et al. Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin Hematol 1994; 31(Suppl 5): 31-7.
12. Eisenhauer EA, Lippman SM, Kavanagh JJ et al. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Leukemia 1994; 8: 1622-5.
13. Rosewicz S, Weder M, Kaiser A et al. Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes. GUT 1996; 39: 255-61.
14. Rosewicz S, Wollbergs K, v.Lampe B et al. Retinoids inhibit adhesion to laminin in human pancreatic carcinoma cells via the alpha6 beta1-integrin receptor. Gastroenterology 1997; 112: 532-42.
15. Petkovich M, Brand NJ, Krust A et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-50.
16. Zelent A, Krust A, Petkovich M et al. Cloning of murine and retinoic acid receptors and a novel receptor predominamely expressed in the skin. Nature 1989; 339: 714-7.
17. Heyman RA, Mangelsdorf, DJ, Dyck JA et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397-406.
18. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid pathway. Trends Biol Sci 1992; 17: 427-33.
19. Giguere V. Retinoic Acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrine Rev 1994; 15: 61-79.
20. Hashimoto Y. Retinobenzoic acids and nuclear retinoic acid receptors. Cell Struct Funct 1991; 16: 113-23.
21. Dolle P, Ruberte E, Leroy P et al. Retinoic acid receptors and cellular retinoid binding proteins. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 1990; 110: 1133-51.
22. Houle B, Rochette-Egly C, Bradley WEC. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993; 90: 985-9.
23. de The H, Chomienne C, Lanotte M et al. The t(17:15) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558-61.
24. Gebert JF, Moghal N, Frangioni JV et al. High frequency of retinoic acid β receptor abnormalities in human lung cancer. Oncogene 1991; 6: 1859-1868.
25. Xu XC, Stier U, Rosewicz S et al. Differential suppression of nuclear retinoic acid receptor beta in pancreatic carcinomas. Int J Oncol 1996; 8: 445-51.
26. Kaiser A, Herbst H, Fisher G et al. Retinoic acid receptor β regulates growth and differentiation in human pancreatic carcinoma cells. Gastroenterology 1997; 113: 920-9.
27. Rosewicz S, Vogt D, Harth N et al. An amphicrine pancreatic cell line: AR42J cells combine exocrine and neuroendocrine properties. Eur J Cell Biol 1992; 59: 80-91.
28. Boylan JF, Lohnes D, Taneja R et al. Loss of retinoic acid receptor γ function by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci USA 1993; 90: 9601-5.
29. Lohnes D, Kastner P, Dierich A et al. Function of retinoic acid receptor γ in the mouse. Cell 1993; 73: 643-58.
30. Kikkawa U, Kishimoto A, Nishizuka Y. The protein kinase C family: heterogeneity and its implications. Annu Rev Biocheml989; 58: 31-44.
31. Basu A. The potential of Protein Kinase C as a target for anticancer treatment. Pharmacol Ther 1993; 5: 257-80.
32. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? J Biochem 1993; 291: 329-43.
33. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-13.
34. Rosewicz S, Brembeck F, Kaiser A et al. Differential growth regulation by all-trans retinoic acid is determined by protein kinase C in human pancreatic carcinoma cells. Endocrinology 1996; 137: 3340-7.
35. Brembeck FH, Schoppmeyer K, Leupold U et al. A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma. Cancer 1998; in press